SBC films are ideal alternative to traditional CFF and PCTFE for pharma products

05

With pharmaceutical companies constantly looking for ways to improve their product packaging with performance-driven, cost-effective solutions, there is an alternative to traditional structures that is making its way into the main stream. Super barrier coated (SBC) films are now being considered for pharma and other healthcare applications.

Tekni-Films, a Tekni-Plex business, has introduced SBC 240 as a performance and improved-cost alternative for 4- and 6-mil PCTFE laminations and cold formed foil for blister applications. This thermoformable film has exceptional moisture and oxygen barrier properties and is designed to meet the needs of pharmaceutical and other healthcare applications. The triplex structure is ideal for applications such as pharmaceuticals, nutraceuticals, probiotics and other related products.

SBC is created by applying a next generation, high-barrier PVdC coating to a lamination of PVC and polyethylene. The PVdC is dispersed in an emulsion, which has been engineered as a surface coating. Multiple layers can be applied to create different coating weights. As coating weight thickness increases, the overall barrier properties also increase.

“For those pharmaceutical companies who may not be well-versed in the various attributes of SBC films, we have created performance data comparisons to CFF and PCTFE, including information on why the material lends itself to smaller pack sizes.  With material usage and environmental concerns at the forefront of every packaging decision, a smaller pack size is an important attribute to consider,” explained Melissa Green, senior director of global marketing for films.